CPRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Catalyst Pharmaceuticals Inc and Microsoft Corporation in 2026
CPRX
Catalyst Pharmaceuticals Inc
$31.49
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | CPRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $3.84B | $3.71T | MSFT |
| P/E Ratio | 13.27 | 33.89 | CPRX |
| EPS (TTM) | $1.75 | $14.08 | MSFT |
| Revenue Growth | 15.3% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze CPRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CPRX or MSFT a better investment?
Comparing CPRX and MSFT: Catalyst Pharmaceuticals Inc has a market cap of $3.84B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CPRX and MSFT?
CPRX (Catalyst Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CPRX or MSFT?
Based on P/E ratios, CPRX trades at a lower multiple (13.3x vs 33.9x).
Which is growing faster: CPRX or MSFT?
MSFT has higher revenue growth at 18.4% vs 15.3% for CPRX.
Which company is more profitable: CPRX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for CPRX.
Which is the larger company: CPRX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $3.84B for CPRX.
Should I buy CPRX or MSFT in 2026?
Both CPRX and MSFT have investment merit. CPRX trades at $31.49 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CPRX and MSFT stock?
Key differences: Market Cap ($3.84B vs $3.71T), P/E Ratio (13.3x vs 33.9x), Revenue Growth (15.3% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy CPRX or MSFT in 2026?
The choice between CPRX and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CPRX and MSFT?
CPRX (Catalyst Pharmaceuticals Inc) has a market cap of $3.84B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.